Best in Biotech 30 Sep 2025 CRISPR technology’s next wave: Ten companies to watch in 2025 Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies. September 30, 2025 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Sep 2025 Eli Lilly’s strategy in motion: Beyond diabetes and obesity Delve into a biopharma giant’s strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals. September 24, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Sep 2025 Navigating German biotech: 14 key players to know The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies. September 23, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 15 Sep 2025 Tapping into the regulatory goldmine: Interview with Ruxandra Teslo The FDA is sitting on a data goldmine: CTds. These documents could help biotech navigate regulations, but how to make them public? September 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2025 With Lykos CRL now public, FDA opens new era of accountability As the release of a CRL declining Lykos’ therapy generates a strong reaction from MAPS, delve into what this new transparency could change. September 8, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 3 Sep 2025 Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field. September 3, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 27 Aug 2025 Zemcelpro, the first blood cord expansion therapy to reach the EU market Find out about ExCellThera’s zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally. August 27, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 22 Aug 2025 The Sanofi pipeline in 2025: Is the play-to-win strategy working? Find out what Sanofi has been up to in 2025, especially as it just closed the Opella deal and is now expanding its pipeline. August 22, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 20 Aug 2025 From pasture to lab: The new biotech toolkit for cattle Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again staring at wounds riddled with maggots. This insect, which devastated cattle in the 20th century, is making a comeback, spurring governments to […] August 20, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2025 How biotech is improving the life of your cat About a week ago, on August 8th, fell International Cat Day. Even if you are a cat person like I am, you might have missed the event. Don’t worry, your feline probably didn’t know about it either. In this article, we will take a look at what biotech is doing in cat health. While the cat […] August 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Jul 2025 Which biotech companies are gaining traction in genetic diseases? Discover twelve companies focused on genetic diseases that managed to close funding rounds in the last two years. July 24, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email